SBT6050 drug page Clinical trials

Trials with SBT6050

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
0Recruiting
1Countries
2Planned patients

Showing 1–1 of 1

A Safety and Activity Study of SBT6050 in Combination With Other HER2-directed Therapies for HER2-positive Cancers
Finished Phase 1 2 patients NCT05091528

This study is designed to assess the safety and preliminary activity of SBT6050 in combination with trastuzumab deruxtecan (Part 1) or tucatinib plus trastuzumab +/- capecitabine (Part 2). Participants will be enrolled into each Arm based …

United States Feb 2022 – Jul 2022 Interventional